Ireland
--:--IST
Latest
Clinical Trials in France / NCT07747571
Starting soon Observational

Factors Associated With Acceptance of Home-Based Pulmonary Telerehabilitation in COPD

NCT07747571 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2026-09-01
Last updated
2026-08-10

Condition(s) studied

Chronic Obstructive Pulmonary Disease (COPD)Pulmonary Rehabilitation

Investigational drug(s) / intervention(s)

No intervention

No intervention: None for the present retrospective study.

Study summary

Pulmonary rehabilitation improves symptoms, exercise capacity, and quality of life in people with chronic obstructive pulmonary disease (COPD), but access and participation may be limited by travel, organizational, logistical, and personal barriers. Home-based pulmonary telerehabilitation may reduce some of these barriers, although not all eligible individuals accept this mode of care. Identifying the characteristics associated with acceptance or refusal of this model is therefore essential to better define the population most likely to benefit from this approach, tailor the program's delivery and content, and identify potential remaining barriers in order to improve access to care.

This retrospective study will use existing data from adults with COPD who were screened at ADIR Association between May 2024 and April 2025 for an 8-week home-based pulmonary telerehabilitation feasibility study. Of 50 potentially eligible individuals, 21 accepted participation and 29 declined. Demographic, clinical, functional, psychological, and geographic characteristics will be compared between individuals who accepted and those who declined participation. Documented reasons for refusal will be described, and factors associated with refusal will be explored using logistic regression.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adults with COPD who were screened at ADIR Association between May 2024 and April 2025 for an 8-week home-based pulmonary telerehabilitation feasibility study. Please refer to ClinicalTrials.gov identifier NCT05314686. Exclusion Criteria: * Not applicable

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
ADIR Association Rouen Normandy

More ADIR Association trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07747571 on ClinicalTrials.gov ↗ ← All trials in France